CORC

在结果中检索

CORC

浏览/检索结果: 共16条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
NFATC2 suppresses the metastatic cascade in breast cancer patients 会议论文
作者:  Chi, Y.;  Chen, J.;  Wu, J.;  Xue, J.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Low serum HBsAg and HBV DNA levels identify strongest responders of pegylated interferon addition to entecavir in HBeAg positive chronic hepatitis B 会议论文
作者:  Liem, K. S.;  Hansen, B. E.;  Xie, Q.;  Chen, L.;  Brouwer, W. P.
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
Baseline and early on-treatment HBsAg level to predict HBsAg loss in nucleotide analog suppressed and HBeAg cleared chronic hepatitis B patients by switching to peginterferon alfa-2a: exploratory results of NEW SWITCH study 会议论文
作者:  Hu, P.;  Xie, Q.;  Li, Y.;  Chen, X.;  Dou, X.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
miR-621 suppresses the metastatic cascade in breast cancer patients 会议论文
作者:  Xue, J.;  Chi, Y.;  Chen, J.;  Yang, B.;  Wu, J.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Increased and sustained HBsAg loss in HBeAg positive CHB patients switched from NUC to Peg-IFN alfa-2a: A randomised open label trial (NEW SWITCH study) 会议论文
作者:  Hu, Peng;  Dou, Xiaoguang;  Jiang, Jian-ning;  Jia, Shang;  Zhang, Wen Hong
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/06
Final Results of Peginterferon Alfa-2b Add-on during Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients - a Multicenter Randomized Controlled Trial (PEGON Study) 会议论文
作者:  Chi, Heng;  Xie, Qing;  Zhang, Ning-Ping;  Qi, Xun;  Liang, Chen
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/13
Nucleos(t)ide Analogue Discontinuation in Patients with HBsAg Loss: Sustained Off-treatment Response Independent of Anti-HBs Status 会议论文
作者:  Chi, Heng;  Lo, Victor;  Peng, Jie;  Cao, Jiawei;  Qi, Xun
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19
PREDICTIVE VALUE OF BASELINE AND ON-TREATMENT qHBsAg LEVEL IN HBeAg POSITIVE CHB PATIENTS WHO SWITCHED FROM NUCS TO PEGYLATED INTERFERON A-2A: A FURTHER ANALYSIS FROM NEW SWITCH STUDY 会议论文
作者:  Hu, P.;  Shang, J.;  Zhang, W.;  Gong, G.;  Li, Yongguo
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/19
A multi-center randomized study on the efficacy and safety of switching to peginterferon alpha-2a (40KD) for 48 or 96 weeks in HBeAg positive CHB patients with a prior NUC history for 1 to 3 years: an interim analysis of NEW SWITCH study 会议论文
作者:  Hu, Peng;  Jia, Shang;  Zhang, Wen Hong;  Gong, Guozhong;  Li, Yongguo
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19
Addition of Peginterferon Alfa-2b During Long-term Nucleos(t)ide Analogue Therapy Increases HBeAg Seroconversion and HBsAg Decline - Week 48 Results From a Multicenter Randomized Controlled Trial (PEGON Study) 会议论文
作者:  Chi, Heng;  Xie, Qing;  Zhang, Ning-Ping;  Qi, Xun;  Liang, Chen
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace